Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multi-institutional assessment of eye lens dose in nuclear medicine clinics.
Abuqbeitah M, Demir M, Işikci NI, Kozanlilar B, Kovan B, Yeyin N, Fikret Çermik T, Şanli Y, Sönmezoğlu K. Abuqbeitah M, et al. Among authors: yeyin n. Nucl Med Commun. 2023 Sep 1;44(9):772-776. doi: 10.1097/MNM.0000000000001727. Epub 2023 Jul 18. Nucl Med Commun. 2023. PMID: 37464817
Selective Intra-Arterial Lutetium-177-Labeled Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: Initial Results.
Sayman HB, Gulsen F, Sager S, Akgun E, Yeyin N, Bilgic S, Toplutas KN, An F, Beytur F, Oklu R, Aras O. Sayman HB, et al. Among authors: yeyin n. J Vasc Interv Radiol. 2022 Mar;33(3):342-345. doi: 10.1016/j.jvir.2021.10.016. Epub 2021 Oct 27. J Vasc Interv Radiol. 2022. PMID: 34715321 Free PMC article. Clinical Trial. No abstract available.
Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study.
Aras O, Demirdag C, Kommidi H, Guo H, Pavlova I, Aygun A, Karayel E, Pehlivanoglu H, Yeyin N, Kyprianou N, Chen N, Harmsen S, Sonmezoglu K, Lundon DJ, Oklu R, Ting R, Tewari A, Akin O, Sayman HB. Aras O, et al. Among authors: yeyin n. Clin Genitourin Cancer. 2021 Oct;19(5):405-416. doi: 10.1016/j.clgc.2021.03.011. Epub 2021 Mar 19. Clin Genitourin Cancer. 2021. PMID: 33879400 Free PMC article.
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
Sager S, Akgün E, Uslu-Beşli L, Asa S, Akovali B, Sahin O, Yeyin N, Demir M, Abuqbeitah M, Gülsen F, Sayman H, Sönmezoglu K. Sager S, et al. Among authors: yeyin n. Nucl Med Commun. 2019 May;40(5):461-468. doi: 10.1097/MNM.0000000000001014. Nucl Med Commun. 2019. PMID: 30896544
20 results